🇫🇷
France · FR · FR:62876801
GALAFOLD 123 mg, gélule
ReimbursedATC A16AX14
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerAMICUS THERAPEUTICS EUROPE (IRLANDE)
CountryFR (France)
ATC codeA16AX14
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400930060827plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 14 gélule(s)EUR 15.91
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "62876801",
"date_amm": "2016-05-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1082",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code A16AX14.
- PLGalafoldAmicus Therapeutics Europe Limited
- 🇨🇭GalafoldAmicus Therapeutics Switzerland GmbH
- DKGalafoldAmicus Therapeutics Europe Ltd
- ISGalafoldAmicus Therapeutics Europe Limited*
- 🇺🇸GalafoldAmicus Therapeutics US, LLC
- NOGalafoldAmicus Therapeutics Europe Limited
- FIGalafoldAmicus Therapeutics Europe Limited
- CZGALAFOLDAmicus Therapeutics Europe Limited, Dublin
Access this data programmatically
Query GALAFOLD 123 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.